Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors - Test2 - elhamkhani - TriplyDB

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

http://www.wikidata.org/entity/Q24537623

about

Model structure of human APOBEC3G Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G The cell biology of HIV-1 and other retroviruses Reconstitution of an infectious human endogenous retrovirus HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity Alternative induction of meiotic recombination from single-base lesions of DNA deaminases Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity Cytidine deamination induced HIV-1 drug resistance Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses Evolution of foamy viruses: the most ancient of all retroviruses Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis Interactions between the HIV-1 Unspliced mRNA and Host mRNA Decay Machineries Selection for robustness in mutagenized RNA viruses Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components Footprint of APOBEC3 on the genome of human retroelements HIV/AIDS epidemiology, pathogenesis, prevention, and treatment Comparison of avian and human influenza A viruses reveals a mutational bias on the viral genomes.Evolution of the influenza a virus: some new advances.SIV replication in human cells Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization.The restriction of zoonotic PERV transmission by human APOBEC3G.Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction.The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals.Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins Are viruses inhibited by APOBEC3 molecules from their host species?Inducible APOBEC3G-Vif double stable cell line as a high-throughput screening platform to identify antiviral compounds.Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo.Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3.Functional annotation of proteome encoded by human chromosome 22.5' to 3' mRNA decay factors colocalize with Ty1 gag and human APOBEC3G and promote Ty1 retrotransposition.Small molecules that inhibit Vif-induced degradation of APOBEC3G.Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.Selective inhibition of Alu retrotransposition by APOBEC3G.Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice

P2860

Q21092257-88FB009A-D493-41FA-8728-FF9D92ECB11D Q21131577-492890D5-C7CD-48F2-940D-69B609256821 Q21245195-C5DE2B06-DAF6-4044-A92B-DE2049B1DE1C Q21245199-4F13FFBD-B9CB-47EF-8772-B5CFDA2F63DF Q21559512-79613680-1880-41D3-BBE3-344FC6C1D536 Q24297395-3D538130-28E3-42AB-9EA8-83A95F449C28 Q24596322-2236DC9E-775A-436E-BEBF-1649F083325F Q24652699-192F7066-7CAD-463F-BA84-0B6291D098E5 Q24655418-27096AF1-F43B-41E5-8BAD-99BC1E5A92FF Q24656551-0EB56D1A-88AE-4287-89AA-0C57036ED7C4 Q24657298-639151C5-0328-4D11-AB04-B851E37AE980 Q24670173-4696FB1C-1909-4FFB-B597-5F79ABCDC960 Q25257798-9535FA03-4481-4422-A7A0-B5AA11107483 Q26852372-4B9E663F-9427-4EA1-85C5-DE8B4FFF582F Q28077209-6B940596-8092-43FF-B60F-7464D05B6CF0 Q28078564-274E6318-00AC-4A13-96C9-9DAB7877A241 Q28469235-556D6315-179B-44BD-AF8F-B8285E5EDE6D Q28482052-DA83C553-0C8F-4E0A-B5B7-A512E6E87E29 Q28680708-4F4E8A1E-3A13-4ACC-B361-014945D44631 Q30356074-904C5808-A07D-448C-B1C3-FAB637EDA545 Q30356963-81D148C8-3390-4C9D-A4C3-125056310E89 Q30376934-1731298B-00A3-4F4D-9E16-84776634FE4F Q30417737-29011580-E72D-4AA3-BA32-7B78A6D049D9 Q30445599-11F5F44A-C28F-4EC2-89A0-CA64256F6CA7 Q30483676-B683633D-F438-4525-B354-CDF82B3792F9 Q33298609-778D5F68-DD42-4722-8DE0-000CFE3FE598 Q33331396-21652256-92C2-4DFA-8834-572E32486B1B Q33385376-6926A7F1-12AF-4AD0-891D-3E38F77A80A0 Q33393637-46A984F6-D19D-4AFA-B871-29B8EA02C71E Q33434458-78DD8363-EEC0-4C14-A3AB-C9CDBC0DE4F9 Q33511412-6EB4FFA7-6C45-4534-9FFD-D100D04FC7C6 Q33530091-F062A372-DDEA-44D9-85F3-1E3D578E9E58 Q33650603-022C03E6-70AC-4FBC-AC50-30F83A801AEA Q33677823-661ED4F6-DD49-470E-B6B0-6567463C6CF5 Q33761772-8A340511-F108-4A4D-8843-8F7DCEB8D525 Q33826821-8EBA3D67-7935-4760-BC2A-C12B18D6D493 Q33857983-3A1AB7D1-FAC1-403B-AC7F-F1492F566DB7 Q34039514-0444ED95-83E0-4CD7-A3D6-257A639686DF Q34048853-E0C87820-B37A-4B37-BB5B-00BA22E56E3E Q34120265-DADBE04D-C7C0-4F2C-ADEA-52DDC986A69F

P2860

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

http://www.wikidata.org/entity/Q24537623

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

@ast

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

@en

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

@en-gb

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

@nl

type

label

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

@ast

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

@en

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

@en-gb

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

@nl

prefLabel

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

@ast

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

@en

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

@en-gb

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

@nl

P1433

Q24537623-6FE8D0B0-9809-433C-9876-FAB2BAC9977A

P1476

Q24537623-9C6CA084-4C3C-4D2D-BADD-450CDAEB0718

P2093

Q24537623-4B474313-B7E9-43C6-BC19-714C8C196245

P2860

Q24537623-00048982-5382-4091-9C2D-51086A86C82B

Q24537623-00B8AEDA-0AE8-461A-8BAE-0300CE31D6A1

Q24537623-01E7EA85-C19C-4523-8EC8-5A3547DF0607

Q24537623-0E9395F5-D118-443B-934D-6C07D925363A

Q24537623-0EED2C70-EF38-40C5-A633-7057CC5F86A7

Q24537623-0F2029F2-2FAC-4B5E-B1EC-EE81E79B3B5D

Q24537623-13A17D91-B1FC-46F3-9D7E-7F2F5FACF952

Q24537623-19849CA9-A795-4E66-92AE-620E98DB22FB

Q24537623-306B7962-0B6F-4937-9936-8E43ACCED24D

Q24537623-32425400-483E-4ECE-B115-FD4137DF46C8

P304

Q24537623-AC20A44B-A4F3-4956-A42C-541C8DDEF54D

P31

Q24537623-65F01D77-5583-49B8-AADC-24415A711D0F

P356

Q24537623-3C78E935-4965-4EDA-851F-BC5D748FCDA3

P407

Q24537623-5B61748E-47C1-4F6F-A6AA-665D64350B39

P433

Q24537623-D766BBDE-23BE-4458-BCA8-08FDADEE2576

P478

Q24537623-3F5E832A-52AB-40AF-99A6-37BDF2175052

P577

Q24537623-142A3765-16B5-4011-A671-AD17A79EA1A6

P698

Q24537623-F6D6A52B-5913-4148-9F96-99EA029C9CF7

P921

Q24537623-C32535D3-C88C-4D7E-B585-41710EA8124F

P932

Q24537623-637CFB96-C503-4296-852D-609060EA7FEA

P356

JVI.80.3.1067-1076.2006

P1433

Journal of Virology

P1476

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

@en

P2093

Bryan R Cullen

http://www.w3.org/2001/XMLSchema#string

P2860

Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities

An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein.

Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.

Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases

Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

P304

1067-1076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.80.3.1067-1076.2006

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16414984

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

1346961

http://www.w3.org/2001/XMLSchema#string